Chongqing Zhifei Biological Products (SHE:300122) swung to an attributable loss of 597.1 million yuan in the first half from an attributable profit of 2.23 billion yuan in the year-ago period, according to a Tuesday filing with the Shenzhen bourse.
The vaccine manufacturer swung to a loss per share of 0.2494 yuan from earnings per share of 0.9322 yuan in the prior-year period.
Operating income decreased 73% to 4.92 billion yuan from 18.3 billion yuan in the year-ago period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments